T

Titan Biotech Limited

TITANBIO
Market snapshot · 2026-08-11 00:59 UTC

398.40

₹-8.65 (-2.13%)

MARKET CAP

₹1.65K Cr

STOCK P/E

55.0x

52W HIGH

₹555.65

52W LOW

₹86.60

BOOK VALUE

₹43.94

EPS

₹7.25

ROE

17.84%

SECTOR

Materials

DEBT/EQUITY

3.14

VOLUME

22,719

P/B RATIO

9.07x

PEG RATIO

Sector

Materials

Themes

Fertilizers & Agro Chemicals
D
Dividend
S
Split
₹504.00₹400.25₹296.50₹192.75₹89.00VolumeDSAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for TITANBIO.

Coverage check

Price Forecast

Current
₹398.40
High Target
Median Target
Low Target
Now₹398.40Aug '25Now12M Target
Price history (1Y)
Analyst target range

Revenue Forecast

₹ Cr
Mar '26Current₹49.0
Sep 2026 ETrend estimate range
High₹75.2Base₹69.6Low₹64.1
Mar '25: ₹35.0 · Jun '25: ₹46.0 · Sep '25: ₹54.0 · Mar '26: ₹49.0 · Sep '26: ₹69.6 · Dec '26: ₹63.2
Mar '25Jun '25Sep '25Mar '26Sep '26 EDec '26 E35.046.054.049.069.663.2
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Mar '26Current₹1.63
Sep 2026 ETrend estimate range
High₹3.16Base₹2.82Low₹2.48
Jun '25: ₹1.66 · Sep '25: ₹1.88 · Dec '25: ₹2.06 · Mar '26: ₹1.63 · Sep '26: ₹2.82 · Dec '26: ₹3.09
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E1.661.882.061.632.823.09
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Neutral
59%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Moderate

Fundamentals institutional score is 67 using EVA spread proxy 5.8%; accruals ratio -2.12; growth durability 97.1.

Valuation

Fairly valued

Valuation institutional score is 0 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Unavailable

This data source has not been supplied for the decision payload.

Market Sentiment

Unavailable

This data source has not been supplied for the decision payload.

Signal Summary

Market intelligence remains Neutral. fundamentals provide support, while valuation remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals ModerateValuation Fairly valued

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical ScoreUnavailable
Fundamental Score67%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 244.4% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.01). Confidence: 50%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

17.79

Current

56.14

Overvalued

27.02

Undervalued

12.60

P/S
Strongly Overvalued

5Y Average

2.58

Current

7.98

Overvalued

2.94

Undervalued

1.09

EV/EBITDA
Strongly Overvalued

5Y Average

13.84

Current

42.74

Overvalued

15.73

Undervalued

5.82

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹49 CrMar 2026

Latest net profit

₹7.00 CrMar 2026

Latest EPS

₹1.63Mar 2026

Net margin

17.2%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%0.00 Cr15 Cr30 Cr45 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr15 Cr30 Cr45 Cr60 Cr₹0₹1₹1₹2₹2
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr15 Cr30 Cr45 Cr60 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 20260.00 Cr55 Cr110 Cr165 Cr220 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹49 Cr

+38.9%

Net Profit

₹7 Cr

+66.3%

EBITDA

₹12 Cr

+98.6%

EPS

₹1.63

+66.3%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales3835465449
Expenses3139464740
Operating Profit488108
OPM %10.6%16.31%14.94%17.23%
Other Income11112
Interest00000
Depreciation11111
Profit before tax5891110
Tax %25.1%24.05%25.56%25.51%36.24%
Net Profit47897
EPS in Rs0.981.661.882.061.63

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...